By uncovering that PKM2 inhibits the RAC1 (rho family, small GTP binding protein) -MAPK (mitogen-activated protein kinase) signaling pathway, they found delayed progression of heart failure and cardiac hypertrophy [236]. The gene discussed is PKM; the disease is heart failure.